ARM

Mark For: ARM® trademark registration is intended to cover the categories of public advocacy to promote awareness of the importance of regenerative medicine, gene therapy, gene editing, cell therapy, tissue-engineering and organ regeneration; lobbying services directed to policy makers, namely, promoting the interests of researchers in the field of regenerative medicine, research institutions in the field of regenerative medicine, patient advocacy groups, and companies developing regenerative medicine products, all in the fields of legislation and regulation; arranging and conducting business partnering forums in the field of regenerative medicine. [all]

Status

2020-01-09 UTC
⟳ Refresh

LIVE APPLICATION Awaiting Examination

Research	OneLook Acronym Finder
Serial Number	88746410
Registration Number	6214671
Mark Literal Elements	ARM
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	SERVICE MARK
Register	PRINCIPAL
Current Location	NEW APPLICATION PROCESSING 2020-01-08
Basis	1(a)
Class Status	ACTIVE
Primary US Classes	100: Miscellaneous 101: Advertising and Business 102: Insurance and Financial
Primary International Class	035 - Primary Class (Advertising and business) Advertising; business management; business administration; office functions.
Filed Use	Yes
Current Use	Yes
Intent To Use	No
Filed ITU	No
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Stephen J. Jeffries

Timeline

IC 035. US 100 101 102. G & S: Public advocacy to promote awareness of the importance of regenerative medicine, gene therapy, gene editing, cell therapy, tissue-engineering and organ regeneration; lobbying services directed to policy makers, namely, promoting the interests of researchers in the field of regenerative medicine, research institutions in the field of regenerative medicine, patient advocacy groups, and companies developing regenerative medicine products, all in the fields of legislation and regulation; arranging and conducting business partnering forums in the field of regenerative medicine. FIRST USE: 20090000. FIRST USE IN COMMERCE: 20090000
IC 041. US 100 101 107. G & S: Conducting workshops and summits in the field of regenerative medicine, gene therapy, gene editing, cell therapy, tissue-engineering and organ regeneration; educational services, namely, providing non-downloadable webinars in the field of regenerative medicine, gene therapy, gene editing, cell therapy, tissue-engineering and organ regeneration. FIRST USE: 20170000. FIRST USE IN COMMERCE: 20170000